Both in R&D — Physical & Biological Sciences
IB Acquisition vs Charles River Laboratories International
Over the past year IBAC returned +3.7% and CRL returned +98.1%; their daily moves had a correlation of -0.01.
IBAC +3.7% CRL +98.1%Growth of $1, one year, split-adjusted
| Metric | IBAC | CRL |
|---|---|---|
| Price | $10.81 | $318.51 |
| Market cap | $54.1M | $15.26B |
| Today | −0.46% | −2.38% |
| 1 month | −0.6% | +6.1% |
| 6 months | −0.2% | +75.3% |
| Year to date | +3.0% | +59.7% |
| 1 year | — | +79.1% |
| Revenue growth (YoY) | — | −2.7% |
| Gross margin | — | 36.2% |
| Net margin | — | −0.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.8× |
| Net cash | — | -$2.43B |
| Dividend yield | — | — |
| Volatility (60d) | 20.1% | 44.7% |
| Short % of float | 0.3% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).